Beximco Pharmaceuticals Limited approved 35% cash dividend for the year ended on 30 June 2021. The cash dividend being 35% of the nominal value per ordinary share of BDT 10 (BDT 3.5 per ordinary share/per global depository receipt ("GDR") held in respect of GDR holders) will be paid to holders of ordinary shares/GDRs (who were on the register of shareholders'/GDR holders' as on the date of record, i.e. 22 November 2021) on or before 20 January 2022. The cash dividend will be paid after deduction of taxes as per Bangladesh Tax law.